Patricia Recordon-Pinson
Overview
Explore the profile of Patricia Recordon-Pinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
White E, Papagno L, Samri A, Sugata K, Hejblum B, Henry A, et al.
Nat Immunol
. 2024 Aug;
25(9):1555-1564.
PMID: 39179934
Human immunodeficiency virus 1 (HIV-1) infection is characterized by a dynamic and persistent state of viral replication that overwhelms the host immune system in the absence of antiretroviral therapy (ART)....
2.
Amrane S, Jaubert C, Bedrat A, Rundstadler T, Recordon-Pinson P, Aknin C, et al.
Nucleic Acids Res
. 2022 Dec;
50(21):12328-12343.
PMID: 36453997
G-quadruplexes (G4s) are four-stranded nucleic acid structures formed by the stacking of G-tetrads. Here we investigated their formation and function during HIV-1 infection. Using bioinformatics and biophysics analyses we first...
3.
Beucher G, Blondot M, Celle A, Pied N, Recordon-Pinson P, Esteves P, et al.
Proc Natl Acad Sci U S A
. 2022 Jun;
119(28):e2202370119.
PMID: 35749382
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections initiate in the bronchi of the upper respiratory tract and are able to disseminate to the lower respiratory tract, where infections can...
4.
Got F, Recordon-Pinson P, Loubano-Voumbi G, Ebourombi D, Blondot M, Metifiot M, et al.
Microorganisms
. 2021 Nov;
9(11).
PMID: 34835480
Background: HIV infects around one hundred thousand patients in the Republic of the Congo. Approximately 25% of them receive an antiretroviral treatment; current first-line regimens include two NRTIs and one...
5.
Recordon-Pinson P, Gosselin A, Ancuta P, Routy J, Fleury H
Gut Pathog
. 2021 Mar;
13(1):20.
PMID: 33757563
One of the approaches to cure human immunodeficiency virus (HIV) is the use of therapeutic vaccination. We have launched the Provir/Latitude 45 study to identify conserved CTL epitopes in archived...
6.
Fleury H, Caldato S, Recordon-Pinson P, Thebault P, Guidicelli G, Hessamfar M, et al.
Viruses
. 2020 Nov;
12(11).
PMID: 33167335
We proposed a new HIV-1 therapeutic vaccine based on conserved cytotoxic T lymphocyte (CTL) epitopes of archived HIV-1 DNA according to their affinity to the dominant HLA-A and -B alleles...
7.
Alves B, Siqueira J, Prellwitz I, Botelho O, Da Hora V, Sanabani S, et al.
Front Microbiol
. 2019 Apr;
10:749.
PMID: 31024510
Approximately 36.7 million people were living with the human immunodeficiency virus (HIV) at the end of 2016 according to UNAIDS, representing a global prevalence rate of 0.8%. In Brazil, an...
8.
Tumiotto C, Alves B, Recordon-Pinson P, Jourdain M, Bellecave P, Guidicelli G, et al.
PLoS One
. 2019 Feb;
14(2):e0212347.
PMID: 30811489
One of the approaches by which the scientific community is seeking to cure HIV is the use of therapeutic vaccination. Previous studies have highlighted the importance of the virus-specific CD8+...
9.
Recordon-Pinson P, Alves B, Tumiotto C, Bellecave P, Bonnet F, Neau D, et al.
AIDS Res Hum Retroviruses
. 2018 Jun;
34(11):1005-1009.
PMID: 29947242
During a recent study on the sequencing data of our database between 2012 and 2016 in Southwestern France, we observed that eight patients harbored what seemed to be the same...
10.
Tumiotto C, Bellecave P, Recordon-Pinson P, Groppi A, Nikolski M, Fleury H
AIDS Res Hum Retroviruses
. 2018 Feb;
34(5):471-473.
PMID: 29439582
We have estimated the prevalence of the different viral subtypes between January 2012 and December 2016 in HIV-1-infected patients of the Aquitaine region (southwest part of France) who had a...